---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005840"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:38:59.700763+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Calidi Biotherapeutics posts updated corporate presentation; details unknown

## Summary
- Company made updated presentation available on its website on February 6, 2026.
- Presentation furnished as Exhibit 99.1 to this Form 8-K under Item 7.01 Regulation FD.
- No specific financial or operational updates disclosed in the filing excerpt provided.
- Presentation content not included in the available text; cannot assess material changes.

## SEC filing metadata
- accession: 0001493152-26-005840
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/0001493152-26-005840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005840
- JSON: https://secwatch.observer/filing/0001493152-26-005840.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005840.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.